SCHEMBL24310690

SCHEMBL24310690

CC(C)c1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccc(N3CCN(C)CC3)cc2)c1C(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ ITK Q08881 1/20 0.34
▸ CCND3 P30281 2/20 0.34
▸ CDK6 Q00534 2/20 0.34
▸ CCNK O75909 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ TTK P33981 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ EGFR P00533 3/20 0.32
▸ CTSC P53634 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCNA2 P20248 1/20 0.32
▸ HRH4 Q9H3N8 5/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ MAP3K7 O43318 1/20 0.31
▸ RPS6KA3 P51812 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309882 0.92 MAP4K1 (0.37) PDE2APDE10AITKCCND3CDK6
SCHEMBL24309719 0.86 MAP4K1 (0.37) PDE2APDE10AITKCCND3CDK6
SCHEMBL24310689 0.83 HTR7 (0.39) PDE2APDE10AITKBRD4MAP3K7
SCHEMBL24310046 0.82 LTA4H (0.34) EGFRCDK1CDK4CCNA2TNK2
SCHEMBL24309392 0.81 BRD4 (0.37) PDE2APDE10AITKCCND3CDK6
SCHEMBL24310424 0.81 PDE2A (0.41) PDE2APDE10AITKCCND3CDK6
SCHEMBL24310428 0.81 MAP4K1 (0.38) PDE2APDE10AITKCCND3CDK6
SCHEMBL24310158 0.80 MAP4K1 (0.37) PDE2APDE10AITKCCND3CDK6
SCHEMBL24310171 0.79 CTSC (0.36) PDE2APDE10AITKCCND3CDK6
SCHEMBL24309791 0.77 AXL (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback